FDA Approvals - Amicus Brief Filed with U.S. Supreme Court in Riegel v.
Amicus Brief Filed with U.S. Supreme Court in Riegel v. Medtronic, Inc. (The San Francisco Examiner)
Filed in Support of Federal Pre-Emption in Riegel v. Medtronic, Inc. WASHINGTON, Oct. 22 /PRNewswire-USNewswire/ -- Leading a group of concerned organizations, the Advanced Medical Technology Association (AdvaMed) filed a joint amicus brief Friday in the U.S. Supreme Court in the matter of Riegel v. Medtronic, Inc . arguing that the FDA should continue to be the sole regulator of medical devices.
(AFX UK Focus) 2007-10-22 15:36 GMT: Genzyme's Renvela gets FDA approval for dialysis patients (Interactive Investor)
BOSTON (Thomson Financial) - Genzyme Corp. said Monday the Food and Drug Administration has approved the company's Renvela drug for the control of serum phosphorus in patients with chronic kidney disease on dialysis.
FDA OKs Genzyme's Renvela (TheStreet.com)
It plans to launch the drug for dialysis patients in the U.S. during the first quarter of next year.